FDA clears Bolt Medical's IVL system, backing Boston Scientific's $664m buyout [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Whilst neither Bolt Medical nor Boston Scientific have publicly unveiled the clearance, the FDA's database lists a 510(k) decision date of 25 th March. Boston Scientific helped establish Bolt Medical in 2019 and has held a 26% stake in the company since. Following promising results for the company's IVL technology, Boston Scientific agreed to acquire a remaining 74% stake in a deal worth up to $664m in January 2025. IVL uses sound waves to break up calcified portions of vessels. The high-frequency, pulsatile pressure fragments calcium lesions using a balloon-based system and helps restore vessel patency. Andrew Thompson, director of therapy research and analysis for medical devices at GlobalData, says that the clearance will see Boston Scientific consolidate its market position given its “already a major player in the percutaneous transluminal angioplasty (PTA) balloon catheter and percutaneous transluminal coronary angioplasty (PTCA) markets.” A Boston Scientific spokesperso
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Truist Financial Corporation from $130.00 to $120.00. They now have a "buy" rating on the stock.MarketBeat
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Boston Scientific (NYSE:BSX) was given a new $131.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- AVeta Medical Appoints Karen Noblett as New CEO [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (NYSE:BSX) had its price target raised by analysts at Royal Bank Of Canada from $125.00 to $130.00. They now have an "outperform" rating on the stock.MarketBeat
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 12/8/25 - Form 3
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- BSX's page on the SEC website